Is CMCXF or MRK a better dividend investment in 2026?

CMCXF currently yields 2222.22% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: CMCXF offers higher current income.

What is the dividend yield difference between CMCXF and MRK?

CMCXF has a forward dividend yield of 2222.22% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 2219.46 percentage points.

Home › Compare › CMCXF vs MRK

CMCXF vs MRK: Dividend Comparison 2026

CMCXF yields 2222.22% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CMCXF wins by $26607504688.20M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CMCXF

● Live price

2222.22%

Share price

$0.09

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26607504688.26M

Annual income

$24,443,703,761,807,280.00

Full CMCXF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — CMCXF vs MRK

📍 CMCXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CMCXF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CMCXF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CMCXF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CMCXF

Annual income on $10K today (after 15% tax)

$188,888.89/yr

After 10yr DRIP, annual income (after tax)

$20,777,148,197,536,188.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, CMCXF beats the other by $20,777,148,197,527,860.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CMCXF + MRK for your $10,000?

CMCXF: 50%MRK: 50%

100% MRK50/50100% CMCXF

Portfolio after 10yr

$13303752344.16M

Annual income

$12,221,851,880,908,540.00/yr

Blended yield

91.87%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CMCXF

No analyst data

Altman Z

-81.2

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CMCXF buys

MRK buys

No recent congressional trades found for CMCXF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCMCXFMRK

Forward yield	2222.22% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$26607504688.26M ✓	$56.8K
Annual income after 10y	$24,443,703,761,807,280.00 ✓	$9,798.13
Total dividends collected	$26455115546.17M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: CMCXF vs MRK ($10,000, DRIP)

Year	CMCXF Portfolio	CMCXF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$232,922	$222,222.22	$11,206	$366.19	+$221.7K → CMCXF
2	$5,086,656	$4,837,429.33	$12,650	$502.35	+$5.07M → CMCXF
3	$104,173,443	$98,730,720.93	$14,407	$694.19	+$104.16M → CMCXF
4	$2,001,166,924	$1,889,701,340.37	$16,585	$967.82	+$2001.15M → CMCXF
5	$36,067,485,611	$33,926,237,001.88	$19,342	$1,363.89	+$36067.47M → CMCXF
6	$610,050,404,477	$571,458,194,873.63	$22,913	$1,947.19	+$610050.38M → CMCXF
7	$9,686,139,336,337	$9,033,385,403,546.24	$27,662	$2,823.89	+$9686139.31M → CMCXF
8	$144,409,519,569,037	$134,045,350,479,156.38	$34,159	$4,173.35	+$144409519.53M → CMCXF
9	$2,022,243,856,495,371	$1,867,725,670,556,501.50	$43,337	$6,308.80	+$2022243856.45M → CMCXF
10	$26,607,504,688,257,330	$24,443,703,761,807,280.00	$56,776	$9,798.13	+$26607504688.20M → CMCXF

CMCXF vs MRK: Complete Analysis 2026

CMCXF — Stock

Walker Lane Resources Ltd. engages in the acquisition and exploration of mineral properties in Canada. The company explores for silver, zinc, lead, gold, copper, antimony, bismuth, and tungsten deposits. Its flagship property is the 100% owned Silver Hart property that includes 116 claims covering an area of 2,017 hectares located in south-central Yukon. The company was formerly known as CMC Metals Ltd. and changed its name to Walker Lane Resources Ltd. in March 2025. Walker Lane Resources Ltd. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Full CMCXF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this CMCXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CMCXF vs SCHD CMCXF vs JEPI CMCXF vs O CMCXF vs KO CMCXF vs MAIN CMCXF vs JNJ CMCXF vs ABBV CMCXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.